Selected Publications:
1. Safoura Zangiabadi and Ali A. Abdul-Sater. Regulation of the NLRP3 Inflammasome by Posttranslational Modifications. The Journal of Immunology, 15, 2022, 208 (2) 286-292; DOI: https://doi.org/10.4049/jimmunol.2100734
2. Maria I Edilova, Jaclyn C Law, Safoura Zangiabadi, Kenneth Ting, Achire Mbanwi, Andrea Arruda, David Uehling, Methvin Isaac, Michael Prakesch, Rima Al-awar, Mark D Minden, Ali A. Abdul-Sater, and Tania H. Watts. (Abdul-Sater and Watts are joint senior authors). The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia. Oncoimmunology – Volume 10, 2021 - Issue 1 https://doi.org/10.1080/2162402X.2021.1943234
3. Maria I. Edilova, Ali Akram and Ali A. Abdul Sater. Innate Immunity Drives Pathogenesis of Rheumatoid Arthritis. Biomedical Journal, 2020 Jul 8:S2319-4170(20)30098-6. doi: 10.1016/j.bj.2020.06.010
4. David Ojcius, Ardavan Jafari, Laxmi Yeruva, Christian Schindler and Ali Abdul-Sater. Dicer controls the activation of NLRP3 inflammasomes. Co-first authors PLoS One 2019 Apr 23;14(4):e0215689. doi: 10.1371/journal.pone.0215689.
5. Dhillon B, Aleithan F, Abdul-Sater Z, Abdul-Sater AA. The Evolving Role of TRAFs in Mediating Inflammatory Responses. Frontiers in Immunology, 2019 Feb doi.org/10.3389/fimmu.2019.00104.
6. Edilova MI, Abdul-Sater AA, Watts TH. TRAF1 Signaling in Human Health and Disease. Frontiers in Immunology, 2018 Dec 18;9:2969. doi: 10.3389/fimmu.2018.02969.
7. Chang YH, Wang KC, Chu KL, Clouthier DL, Tran AT, Torres Perez MS, Zhou AC, Abdul-Sater AA, Watts TH. Dichotomous Expression of TNF Superfamily Ligands on Antigen-Presenting Cells Controls Post-priming Anti-viral CD4+ T Cell Immunity. Immunity, 2017 Nov 21;47(5):943-958
8. Abdul-Sater AA, Edilova MI, Clouthier DL, Mbanwi A, Kremmer E, Watts TH. The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease. Nature Immunology, 2017 Jan;18(1):26-35. doi: 10.1038/ni.3618. Highlighted by Nature Reviews Rheumatology: Reduced TRAF1 exacerbates inflammation. doi:10.1038/nrrheum.2016.203
9. Abdul-Sater AA, Majoros A, Plumlee CR, Perry S, Gu AD, Lee C, Shresta S, Decker T, Schindler C. Different STAT transcription complexes drive early and delayed responses to type I Interferons. The Journal of Immunology, 2015 Jul 1;195(1):210-6. doi: 10.4049/jimmunol.1401139
10. Abdul-Sater AA, Tattoli I, Jin L, Grajkowski A, Levi A, Koller BH, Allen IC, Beaucage SL, Fitzgerald KA, Ting JP, Cambier JC, Girardin SE, Schindler C. Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome. EMBO Reports 2013 Sep 6. doi: 10.1038/embor.2013.132
A complete list of publications can be accessed through this link: https://pubmed.ncbi.nlm.nih.gov/?term=abdul-sater+aa&sort=date